Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance · 2 days ago
Open | 139.85 |
High | 142.79 |
Low | 139.68 |
Mkt Cap | 635.68B |
P/E (TTM) | 49.39 |
Div & Yield | 1.37 & 0.98% |
Prev. Close | 140.43 |
52 Wk. Low | 75.96 |
52 Wk. High | 148.15 |
Related stocks
Danish pharmaceutical company
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 65.35B | 22.50% ▲ |
Net Income | 25.41B | 28.20% ▲ |
Diluted EPS | 0.82 | 29.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.73 | - |
Q1 2024 | $0.75 | $0.82 |
Q4 2023 | $0.64 | $0.70 |
S&P 500^GSPC | 5,633.91+56.93 (+1.02%) |
Dow 30^DJI | 39,721.36+429.39 (+1.09%) |
Nasdaq^IXIC | 18,647.45+218.16 (+1.18%) |
5.07+22.46% | |
884.31-0.29% | |
HubSpot, Inc.HUBS | 492.31-12.12% |